«

»

AstraZeneca Seeks Emergency Use Authorization In U.S. For Covid Prophylaxis Drug

Late-stage trials of the drug show it is 77% effective in reducing the risk of Covid-19 symptoms if administered as a preventive treatment.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive